Lowest-Rated Stocks NASDAQ:SYNH Syneos Health - SYNH Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Syneos Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $37.93 -0.29 (-0.76%) (As of 02/8/2023 12:00 AM ET) Add Compare Share Share Today's Range$37.76▼$38.6050-Day Range$33.96▼$38.2252-Week Range$22.89▼$92.57Volume526,527 shsAverage Volume1.61 million shsMarket Capitalization$3.90 billionP/E Ratio13.79Dividend YieldN/APrice Target$53.60 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Syneos Health MarketRank™ ForecastAnalyst RatingHold2.10 Rating ScoreUpside/Downside41.3% Upside$53.60 Price TargetShort InterestBearish7.10% of Float Sold ShortDividend StrengthN/ASustainability-1.00Upright™ Environmental ScoreNews Sentiment1.13Based on 8 Articles This WeekInsider TradingN/AProj. Earnings Growth-23.35%From $4.24 to $3.25 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.17 out of 5 starsMedical Sector396th out of 1,026 stocksCommercial Physical Research Industry5th out of 17 stocks 3.1 Analyst's Opinion Consensus RatingSyneos Health has received a consensus rating of Hold. The company's average rating score is 2.10, and is based on 2 buy ratings, 7 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $53.60, Syneos Health has a forecasted upside of 41.3% from its current price of $37.93.Amount of Analyst CoverageSyneos Health has only been the subject of 2 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted7.10% of the float of Syneos Health has been sold short.Short Interest Ratio / Days to CoverSyneos Health has a short interest ratio ("days to cover") of 4.3.Change versus previous monthShort interest in Syneos Health has recently increased by 19.64%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldSyneos Health does not currently pay a dividend.Dividend GrowthSyneos Health does not have a long track record of dividend growth. Previous Next 4.5 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreSyneos Health has received a 70.43% net impact score from Upright. The largest positive contribution comes from its "Creating knowledge" impact, which is mostly driven by its "Clinical research services for physical health", "Clinical research services for mental health", and "Management consulting for medical technology industry" products. See details.Environmental SustainabilityThe Environmental Impact score for Syneos Health is -1.00. Previous Next 2.9 News and Social Media Coverage News SentimentSyneos Health has a news sentiment score of 1.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Syneos Health this week, compared to 3 articles on an average week.MarketBeat FollowsOnly 2 people have added Syneos Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Syneos Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.34% of the stock of Syneos Health is held by insiders.Percentage Held by Institutions93.51% of the stock of Syneos Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Syneos Health are expected to decrease by -23.35% in the coming year, from $4.24 to $3.25 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Syneos Health is 13.79, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 150.62.Price to Earnings Ratio vs. SectorThe P/E ratio of Syneos Health is 13.79, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 163.13.Price to Book Value per Share RatioSyneos Health has a P/B Ratio of 1.15. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Syneos Health (NASDAQ:SYNH) StockSyneos Health, Inc. engages in the provision of outsourced clinical development and commercialization services to biopharmaceutical companies. It operates through the following business segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers clinical development services spanning Phase I to Phase IV, including global studies, as well as unbundled service offerings such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services, including outsourced field selling solutions, medication adherence, communications, and consulting services. The company was founded in 1998 and is headquartered in Morrisville, NC.Read More Receive SYNH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Syneos Health and its competitors with MarketBeat's FREE daily newsletter. Email Address SYNH Stock News HeadlinesFebruary 8, 2023 | finance.yahoo.comSyneos Health Schedules Fourth Quarter and Full Year 2022 Earnings Call for Thursday, February 16th, 2023February 8, 2023 | finance.yahoo.comSyneos Health Partners with Equicare, Optimizing Data Capture and Integration to Accelerate Clinical Trial ResearchFebruary 9, 2023 | Legacy Research (Affiliate) (Ad)Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapseThe One Ticker Retirement Plan How to make all the money you need – in any market – using a single stock.February 7, 2023 | finance.yahoo.comSyneos Health and Haystack Health Partner to Accelerate Clinical Trials with AIFebruary 6, 2023 | americanbankingnews.comSyneos Health, Inc. (NASDAQ:SYNH) Receives Average Rating of "Hold" from BrokeragesJanuary 26, 2023 | finance.yahoo.comSyneos Health (SYNH) Signs New Partnership With CryoportJanuary 18, 2023 | finance.yahoo.comImplied Volatility Surging for Syneos Health (SYNH) Stock OptionsJanuary 18, 2023 | markets.businessinsider.comCryoport Announces Strategic Partnership With Syneos HealthFebruary 9, 2023 | Legacy Research (Affiliate) (Ad)Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapseThe One Ticker Retirement Plan How to make all the money you need – in any market – using a single stock.January 11, 2023 | finanznachrichten.deSyneos Health, Inc.: Syneos Health Announces Partnership with Fosun Pharma USA to Launch SerplulimabJanuary 11, 2023 | msn.comSyneos, Fosun Pharma team up to launch lung cancer drug serplulimab in USJanuary 10, 2023 | finance.yahoo.comSyneos Health executive to depart with $1M severance after rough 2022January 10, 2023 | finance.yahoo.comSyneos Health Dealmakers’ Intentions Survey Sees “Optimism” for M&A and Licensing Deals in 2023January 9, 2023 | msn.comSyneos Health CFO Meggs to leave companyJanuary 9, 2023 | finance.yahoo.comSyneos Health Announces Chief Financial Officer TransitionJanuary 5, 2023 | finance.yahoo.com2023 Faces to Watch: Syneos Health CEO Michelle KeefeJanuary 3, 2023 | finance.yahoo.comSyneos Health to Present at the 41st Annual J.P. Morgan Healthcare ConferenceDecember 30, 2022 | finance.yahoo.comSyneos Health (SYNH) Hurt by Low Reimbursable Expense, FX IssueDecember 15, 2022 | msn.comSyneos Health slips as Mizuho downgrades on demand outlookDecember 13, 2022 | finance.yahoo.comSyneos Health (NASDAQ:SYNH) investors are sitting on a loss of 65% if they invested a year agoDecember 13, 2022 | finance.yahoo.comSyneos Health Extends Partnership with MedableDecember 12, 2022 | finanznachrichten.deTetris Pharma signs service agreement with Syneos HealthDecember 9, 2022 | seekingalpha.comSyneos Health: Headwinds Already Priced In, But We Rate It A HoldDecember 1, 2022 | finance.yahoo.comSyneos Health Releases 2023 Health TrendsNovember 28, 2022 | msn.comSyneos Health Earnings Perspective: Return On Capital EmployedNovember 23, 2022 | finance.yahoo.comSyneos Health, Inc.'s (NASDAQ:SYNH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?November 21, 2022 | finance.yahoo.comIs Investing in Syneos Health (SYNH) Risky?See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SYNH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Syneos Health and its competitors with MarketBeat's FREE daily newsletter. Email Address SYNH Company Calendar Last Earnings11/03/2021Today2/08/2023Next Earnings (Estimated)2/16/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Commercial physical research Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SYNH CUSIPN/A CIK1610950 Webwww.syneoshealth.com Phone(919) 876-9300Fax919-876-9360Employees28,000Year FoundedN/APrice Target and Rating Average Stock Price Forecast$53.60 High Stock Price Forecast$81.00 Low Stock Price Forecast$25.00 Forecasted Upside/Downside+41.3%Consensus RatingHold Rating Score (0-4)2.10 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)$2.75 Trailing P/E Ratio13.79 Forward P/E Ratio8.95 P/E GrowthN/ANet Income$234.83 million Net Margins5.31% Pretax Margin7.22% Return on Equity14.01% Return on Assets5.69% Debt Debt-to-Equity Ratio0.84 Current Ratio1.14 Quick Ratio1.14 Sales & Book Value Annual Sales$5.21 billion Price / Sales0.75 Cash Flow$6.35 per share Price / Cash Flow5.97 Book Value$32.91 per share Price / Book1.15Miscellaneous Outstanding Shares102,900,000Free Float102,554,000Market Cap$3.90 billion OptionableOptionable Beta1.65 Key ExecutivesMichelle KeefeChief Executive Officer & DirectorMichael BrooksChief Operating OfficerJason Michael MeggsChief Financial OfficerLarry A PickettChief Information & Digital OfficerBaba ShettyPresident-Technology & Data SolutionsKey CompetitorsMedpaceNASDAQ:MEDPCharles River Laboratories InternationalNYSE:CRLVir BiotechnologyNASDAQ:VIRGinkgo BioworksNYSE:DNAMaravai LifeSciencesNASDAQ:MRVIView All CompetitorsInsiders & InstitutionsSwiss National BankBought 4,600 shares on 2/8/2023Ownership: 0.241%Arizona State Retirement SystemBought 1,091 shares on 2/8/2023Ownership: 0.028%Skandinaviska Enskilda Banken AB publ Sold 1,451 shares on 2/8/2023Ownership: 0.024%FORA Capital LLCBought 10,991 shares on 2/8/2023Ownership: 0.011%UBS Group AGSold 2,783 shares on 2/8/2023Ownership: 0.008%View All Insider TransactionsView All Institutional Transactions SYNH Stock - Frequently Asked Questions Should I buy or sell Syneos Health stock right now? 10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Syneos Health in the last year. There are currently 1 sell rating, 7 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SYNH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SYNH, but not buy additional shares or sell existing shares. View SYNH analyst ratings or view top-rated stocks. What is Syneos Health's stock price forecast for 2023? 10 brokers have issued 12 month price objectives for Syneos Health's shares. Their SYNH share price forecasts range from $25.00 to $81.00. On average, they expect the company's share price to reach $53.60 in the next twelve months. This suggests a possible upside of 41.3% from the stock's current price. View analysts price targets for SYNH or view top-rated stocks among Wall Street analysts. How have SYNH shares performed in 2023? Syneos Health's stock was trading at $36.68 at the beginning of 2023. Since then, SYNH stock has increased by 3.4% and is now trading at $37.93. View the best growth stocks for 2023 here. Are investors shorting Syneos Health? Syneos Health saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 7,250,000 shares, an increase of 19.6% from the December 31st total of 6,060,000 shares. Based on an average daily volume of 1,700,000 shares, the short-interest ratio is currently 4.3 days. Approximately 7.1% of the shares of the company are short sold. View Syneos Health's Short Interest. When is Syneos Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, February 16th 2023. View our SYNH earnings forecast. How were Syneos Health's earnings last quarter? Syneos Health, Inc. (NASDAQ:SYNH) announced its earnings results on Wednesday, November, 3rd. The company reported $1.22 EPS for the quarter, beating analysts' consensus estimates of $1.17 by $0.05. The company earned $1.35 billion during the quarter, compared to analyst estimates of $1.34 billion. Syneos Health had a trailing twelve-month return on equity of 14.01% and a net margin of 5.31%. The business's quarterly revenue was up 22.7% on a year-over-year basis. During the same period in the prior year, the business posted $0.93 EPS. What guidance has Syneos Health issued on next quarter's earnings? Syneos Health updated its FY 2022 earnings guidance on Monday, January, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $5.30 billion-$5.36 billion, compared to the consensus revenue estimate of $5.32 billion. What is Alistair Macdonald's approval rating as Syneos Health's CEO? 322 employees have rated Syneos Health Chief Executive Officer Alistair Macdonald on Glassdoor.com. Alistair Macdonald has an approval rating of 82% among the company's employees. What other stocks do shareholders of Syneos Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Syneos Health investors own include NVIDIA (NVDA), Pfizer (PFE), Block (SQ), Advanced Micro Devices (AMD), Boeing (BA), Alibaba Group (BABA), ICON Public (ICLR), Netflix (NFLX), AbbVie (ABBV) and Intel (INTC). What is Syneos Health's stock symbol? Syneos Health trades on the NASDAQ under the ticker symbol "SYNH." Who are Syneos Health's major shareholders? Syneos Health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Cooke & Bieler LP (1.83%), Boston Partners (1.11%), Assenagon Asset Management S.A. (1.03%), California Public Employees Retirement System (0.49%), Reinhart Partners Inc. (0.40%) and New York State Common Retirement Fund (0.30%). Insiders that own company stock include Alistair Macdonald, Donna Hildebrand Kralowetz, International Corp/Ma Advent, Jason M Meggs, John L Maldonado, John M Dineen, Jonathan Olefson, Linda S Harty, Mark E Jagiela, Matthew E Monaghan, Matthew E Monaghan, Michael Lee Brooks, Michelle Keefe, Paul Colvin, Robert Parks, Thomas H Lee Advisors, Llc and Tom Allen. View institutional ownership trends. How do I buy shares of Syneos Health? Shares of SYNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Syneos Health's stock price today? One share of SYNH stock can currently be purchased for approximately $37.93. How much money does Syneos Health make? Syneos Health (NASDAQ:SYNH) has a market capitalization of $3.90 billion and generates $5.21 billion in revenue each year. The company earns $234.83 million in net income (profit) each year or $2.75 on an earnings per share basis. How many employees does Syneos Health have? The company employs 28,000 workers across the globe. How can I contact Syneos Health? Syneos Health's mailing address is 1030 Sync Street, Morrisville NC, 27560. The official website for the company is www.syneoshealth.com. The company can be reached via phone at (919) 876-9300, via email at investor.relations@syneoshealth.com, or via fax at 919-876-9360. This page (NASDAQ:SYNH) was last updated on 2/9/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.